The MONET - Study: MR Mammography of Nonpalpable Breast Tumors (MONET)
Primary Purpose
Breast Neoplasms
Status
Unknown status
Phase
Phase 4
Locations
Netherlands
Study Type
Interventional
Intervention
Contrast-enhanced MR mammography
Sponsored by
About this trial
This is an interventional diagnostic trial for Breast Neoplasms focused on measuring Magnetic Resonance Imaging, Breast Neoplasms, Diagnostic Trial
Eligibility Criteria
Inclusion Criteria: patients with a nonpalpable, mammographically suspicious breast lesion (BI-RADS 3, 4 or 5) referred for large core needle biopsy 18 to 75 years Exclusion Criteria: previous breast surgery or radiation therapy of the breast less than 9 months before MR mammography pregnant or lactating claustrophobia or adiposity ( > 130 kg) general contraindications for MRI unable to maintain prone position for one hour medically unstable patients
Sites / Locations
- Meander Medisch CentrumRecruiting
- Albert Schweitzer ZiekenhuisRecruiting
- Unicersity Medical Center UtrechtRecruiting
Outcomes
Primary Outcome Measures
The absolute number of surgical procedures in women with nonpalpable malignancies will be compared between MRI group and control group.
Secondary Outcome Measures
The number of large core needle biopsies that can be prevented because of a definite diagnosis as provided by MRI will be calculated.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00302120
Brief Title
The MONET - Study: MR Mammography of Nonpalpable Breast Tumors
Acronym
MONET
Official Title
MR Mammography: Randomized Controlled Trial to Study Efficiency of MR Mammography in Reducing the Number of Invasive Interventions in Nonpalpable Suspicious Breast Lesions. The MONET - Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2008
Overall Recruitment Status
Unknown status
Study Start Date
February 2006 (undefined)
Primary Completion Date
March 2009 (Anticipated)
Study Completion Date
March 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
UMC Utrecht
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine whether performing MRI of the breast will improve breast cancer management by reducing the number of biopsies and in case of malignancy allowing one-stage surgical excision of the tumor.
Detailed Description
Each year 7000 women present with nonpalpable suspicious breast lesions on mammography in the Netherlands. In the usual care situation, these lesions are detected by mammography and ultrasonography and pathologically characterized by analysis of large core needle biopsy material. In case of malignancy, these lesions are surgically removed. First, a wire is placed in the breast with the tip of the wire within 1 cm of the tumor and then the surgeon follows the wire and removes the lesion. Unfortunately about 25% of women require more that one surgical procedure to remove all tumorous tissue. This is caused by incorrect presurgical diagnosis of the extent and invasiveness of the disease (multifocality, multicentricity, lymph node involvement). We hypothesize that MR mammography will improve presurgical diagnosis and differentiation of lesions and thereby decrease the number of invasive surgical procedures (primary outcome) and number of invasive biopsies (secondary outcome).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Neoplasms
Keywords
Magnetic Resonance Imaging, Breast Neoplasms, Diagnostic Trial
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
440 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Contrast-enhanced MR mammography
Primary Outcome Measure Information:
Title
The absolute number of surgical procedures in women with nonpalpable malignancies will be compared between MRI group and control group.
Time Frame
2010
Secondary Outcome Measure Information:
Title
The number of large core needle biopsies that can be prevented because of a definite diagnosis as provided by MRI will be calculated.
Time Frame
2009
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients with a nonpalpable, mammographically suspicious breast lesion (BI-RADS 3, 4 or 5)
referred for large core needle biopsy
18 to 75 years
Exclusion Criteria:
previous breast surgery or radiation therapy of the breast less than 9 months before MR mammography
pregnant or lactating
claustrophobia or adiposity ( > 130 kg)
general contraindications for MRI
unable to maintain prone position for one hour
medically unstable patients
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicky HG Peters, MD
Phone
0031302503196
Email
n.peters@umcutrecht.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Petra HM Peeters, MD PhD
Phone
0031302509363
Email
p.h.m.peeters@umcutrecht.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Willem P Mali, MD PhD
Organizational Affiliation
UMC Utrecht
Official's Role
Study Director
Facility Information:
Facility Name
Meander Medisch Centrum
City
Amersfoort
ZIP/Postal Code
3818 ES
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Albert Schweitzer Ziekenhuis
City
Dordrecht
ZIP/Postal Code
3300 AK
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Unicersity Medical Center Utrecht
City
Utrecht
ZIP/Postal Code
3584 CX
Country
Netherlands
Individual Site Status
Recruiting
12. IPD Sharing Statement
Citations:
PubMed Identifier
18045470
Citation
Peters NH, Borel Rinkes IH, Mali WP, van den Bosch MA, Storm RK, Plaisier PW, de Boer E, van Overbeeke AJ, Peeters PH. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Trials. 2007 Nov 28;8:40. doi: 10.1186/1745-6215-8-40.
Results Reference
derived
Learn more about this trial
The MONET - Study: MR Mammography of Nonpalpable Breast Tumors
We'll reach out to this number within 24 hrs